Genzyme crunches consent-decree fine numbers; SAFC expands for dry powder media;

> Genzyme says it anticipates a $175-million penalty in the forthcoming FDA consent decree for its Boston area manufacturing plant, in addition to percentage-of-revenue fines for any operations-corrections deadlines it misses going forward. Genzyme release

> Sigma-Aldrich company SAFC is spending $6.15 million to expand its Lenexa, KS, facility for the upstream and downstream production of dry powder media and reagents. SAFC release

> Former FDA commissioner Andrew von Eschenbach has joined the scientific advisory board of nanotechnology company Arrowhead Research. Arrowhead release

> The Chao Center for Industrial Pharmacy and Contract Manufacturing at Purdue Research Park is closing its doors. Item

> Kimberly-Clark Professional has introduced the Kimtech Pure G3 and G5 sterling nitrile cleanroom gloves. Article